Standout Papers
Citation Impact
Citing Papers
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
2009
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Bone Disease after Renal Transplantation
2006
Phosphorus Binders and Survival on Hemodialysis
2008
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death
2008
A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims Data
2008
Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD
2005
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
2007
The fallacy of the calcium-phosphorus product
2007
Acute kidney injury
2012 Standout
Progression of Coronary Artery Calcification in Predialysis Patients
2007
Vascular Calcification Mechanisms
2004 Standout
A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
2008
Oral Phosphate Binders in Patients with Kidney Failure
2010
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
Calcimimetic R-568 Decreases Extraosseous Calcifications in Uremic Rats Treated with Calcitriol
2006
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
A Randomized Crossover Trial Comparing Sevelamer With Calcium Acetate in Children With CKD
2006
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Calcium, Phosphate, and Parathyroid Hormone Levels in Combination and as a Function of Dialysis Duration Predict Mortality
2004
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
2005
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
2006
Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate
2005
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
2007
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
2005
Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3
2005
Vitamin D Deficiency
2007 Standout
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
2002
Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone
2008
The Effects of Sevelamer Hydrochloride and Calcium Carbonate on Kidney Calcification in Uremic Rats
2002
The renal osteodystrophy pattern in Brazil and Uruguay: An overview
2003
Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease
2004
Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
2007
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
2005
Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients
2006
Slowing the Progression of Vascular Calcification in Hemodialysis
2003
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
2004
Bile acid sequestrants
2011
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study
2004
Emerging drugs for hyperphosphatemia
2007
Role of Calcium-Phosphate Product and Bone-Associated Proteins on Vascular Calcification in Renal Failure
2001
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients
2003
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
2004 Standout
Diabetes in Asia
2009 Standout
Acute kidney injury
2019 Standout
Association of renal function with cardiac calcifications in older adults: the cardiovascular health study
2008
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
2003 Standout
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
2003
Kidney Function and Aortic Valve and Mitral Annular Calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
2007
Natural history of vascular calcification in dialysis and transplant patients
2004
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study
2006
Cardiorenal Syndrome
2008 Standout
The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients
2003
Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients
2007
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
2004
Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
2007
Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives
2005
Sevelamer Controls Parathyroid Hormone–Induced Bone Disease as Efficiently as Calcium Carbonate without Increasing Serum Calcium Levels during Therapy with Active Vitamin D Sterols
2005
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
2008
Survival following parathyroidectomy among United States dialysis patients
2004
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients
2005
Chronic kidney disease: global dimension and perspectives
2013 Standout
New Therapies for Reducing Low-Density Lipoprotein Cholesterol
2014
Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients
2006
Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
2005
Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease
2011
Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients
2004
Pathogenesis of vascular calcification in chronic kidney disease
2005
Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy
2006
Relationship between circulating FGF23 and total body atherosclerosis in the community
2009
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
2009
Accelerated Atherosclerotic Calcification and Mo[Combining Diaeresis]nckeberg's Sclerosis
2008
Klotho converts canonical FGF receptor into a specific receptor for FGF23
2006 StandoutNature
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
2005
Arterial structure and function in end-stage renal disease
2002
Aortic calcification in haemodialysis patients with diabetes mellitus
2005
Impact of Dyslipidemia in End-Stage Renal Disease
2003
Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study
2007
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance
2016
Low Turnover Osteodystrophy and Vascular Calcification Are Amenable to Skeletal Anabolism in an Animal Model of Chronic Kidney Disease and the Metabolic Syndrome
2005
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins
2002
Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects
2001
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
2007
The dawning era of polymer therapeutics
2003 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment
2007
Calcification of Coronary Intima and Media
2006
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Assessment of Coronary Artery Calcification in Hemodialysis Patients Using Multi-Detector Spiral CT Scan
2004
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis
2004
Decrease in Thoracic Vertebral Bone Attenuation With Calcium-Based Phosphate Binders in Hemodialysis
2005
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Increased risk of mortality associated with hip fracture in the dialysis population
2004
Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification
2006
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Bone metabolism and disease in chronic kidney disease
2003
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Vascular Calcification
2008 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Renal problems after lung transplantation of cystic fibrosis patients
2001
Works of Maureen Dillon being referenced
A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
1999
Cardiac calcification in adult hemodialysis patients
2002 Standout
A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis
2007
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
2007
Colesevelam Hydrochloride (Cholestagel)
1999
Results of a Randomized Crossover Study Comparing Once-Daily and Thrice-Daily Sevelamer Dosing
2006
Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*
1999
Sevelamer with and without calcium and vitamin D: Observations from a long-term open-label clinical trial
2000
Hyperparathyroidism and dialysis vintage.
2000
Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients
2003
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
1999
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
1999